# Partha Basu

Source: https://onco.cc/people/basu-partha/  
OnCo record `basu-partha` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Leads IARC's early detection and prevention work, central to the WHO cervical cancer elimination strategy.

## Summary

Partha Basu is Head of the Early Detection, Prevention and Infections Branch at the International Agency for Research on Cancer. A gynaecologic oncologist, he leads IARC's early detection and prevention work, which is central to the WHO cervical cancer elimination strategy, running implementation research on HPV vaccination and screening, particularly in low- and middle-income countries. His publications include a report on HPV vaccination and cervical screening across Asian National Cancer Centers Alliance member countries, a description of IARC's role in strengthening cancer prevention and early detection, and an argument for gender-neutral HPV vaccination. His interests include HPV DNA testing and self-sampling in low-resource settings.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Head, Early Detection, Prevention and Infections Branch, IARC
- Specialisms: Cervical cancer screening; HPV; Early detection in low-resource settings; Implementation research

## Sources

- IARC: https://www.iarc.who.int
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Basu%20P%5BAuthor%5D%20IARC%20cervical%20screening

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- technologies: [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/), [HPV DNA testing and self-sampling](https://onco.cc/technologies/hpv-testing/)
- institutions: [International Agency for Research on Cancer (IARC / WHO)](https://onco.cc/institutions/iarc/)
- journals: [Journal of the National Cancer Institute. Monographs](https://onco.cc/journals/jnci-monographs/)
- trials: [IARC India HPV vaccine dose study (one, two or three doses)](https://onco.cc/trials/iarc-india-hpv-dose-study/)
- key papers: [Vaccine efficacy against persistent HPV 16/18 infection at 10 years after one, two and three doses of quadrivalent HPV vaccine in girls in India](https://onco.cc/key-papers/paper-basu-single-dose-hpv-lancet-oncol-2021/)

---
JSON: https://onco.cc/api/v1/entities/basu-partha.json